(Q51696215)

9 April 2018

title

Hepatitis C infection and survivals of liver transplant patients in Canada, 1997-2003. (English)

1 reference

9 April 2018

0 references

Z Hong

1

1 reference

9 April 2018

G Smart

2

1 reference

9 April 2018

M Dawood

3

1 reference

9 April 2018

K Kaita

4

1 reference

9 April 2018

S-W Wen

5

1 reference

9 April 2018

J Gomes

6

1 reference

9 April 2018

J Wu

7

1 reference

9 April 2018

language of work or name

English

0 references

publication date

1 June 2008

1 reference

9 April 2018

Transplantation Proceedings

published in

1 reference

9 April 2018

volume

40

1 reference

9 April 2018

issue

5

1 reference

9 April 2018

page(s)

1466-1470

1 reference

9 April 2018

Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Hepatitis C virus and liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Hepatitis C: a review for primary care physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Survival analysis of liver transplant patients in Canada 1997-2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

The management of chronic viral hepatitis: a Canadian consensus conference 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Revisiting posttransplant survival for hepatitis C virus recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

[Long-term results after liver transplantation]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

[The recurrence of hepatitis C virus after liver transplantation].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

The association between hepatitis C infection and survival after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Host and donor risk factors before and after liver transplantation that impact HCV recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Long-term outcome of hepatitis C infection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Management of recurrent hepatitis C in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Outcome and management of hepatitis C in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

Liver transplantation for hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.089

10.1016/J.TRANSPROCEED.2008.03.089

7 January 2021

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

18589130

1 reference

9 April 2018